SEEKYO® is a privately-owned biotech company developing the next generation of chemotherapies, providing cancer patient efficient treatment without adverse effects. We are designing smart drugs that selectively target the microenvironment of solid tumors while sparing healthy tissues. Seekyo’s Smart Drugs transport potent anticancer agents in an innocuous manner toward safe tissues, provide efficient recognition of malignan...
SEEKYO® is a privately-owned biotech company developing the next generation of chemotherapies, providing cancer patient efficient treatment without adverse effects. We are designing smart drugs that selectively target the microenvironment of solid tumors while sparing healthy tissues. Seekyo’s Smart Drugs transport potent anticancer agents in an innocuous manner toward safe tissues, provide efficient recognition of malignant specificities thanks to its targeting unit and allow the controlled release of the parent drug exclusively at the tumour site, based on its versatile enzyme-responsive self-immolative linker.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.